clorazepate dipotassium has been researched along with Symptom Cluster in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrer-Dufol, A; Marques-Alamo, JM; Murillo, EC; Perez-Aradros, C | 1 |
| Bourgeois, M; Daubech, JF; Delile, JM; Goumilloux, R; Jordan, M; Rigal, F | 1 |
2 other study(ies) available for clorazepate dipotassium and Symptom Cluster
| Article | Year |
|---|---|
Fatal serotonin syndrome caused by moclobemide-clomipramine overdose.
Topics: Adult; Benzamides; Clomipramine; Clorazepate Dipotassium; Drug Interactions; Drug Overdose; Fatal Outcome; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Syndrome | 1998 |
[Depersonalization, Cotard's syndrome and tendency toward mania under benzodiazepine (apropos of 2 case reports)].
Topics: Adult; Anti-Anxiety Agents; Clorazepate Dipotassium; Depersonalization; Female; Humans; Paranoid Personality Disorder; Personality Disorders; Psychoses, Substance-Induced; Syndrome | 1986 |